Thyroid and antithyroid drugs. Hypothalamic and pituitary hormones Flashcards

1
Q

Hyperthyreosis (symptoms and Causes)

A
  1. Symptoms • Subjective symtoms: nervosity, anxiety, insomnia, tremor, palpitations, heat intolerance, increased GI motility • Objective symptoms: weight loss, increased glucose, tachiarrhythmias, hair loss, cholesterin reduced, wet and warm skin; in case of Basedow: exophtalmus, pretibial edemas 2. Causes Immunological (Graves’ disease) • TSH-receptor-antibodies stimulate the thyroid gland Multinodular goiter (Thyroid adenoma) • nodules grow up and secrete thyroid hormone autonomously Hypersecretion of thyroid stimulating hormone • pituitary adenoma, T3-resistent Thyroid cancer (rare)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Tx of Hyperthyeosis

A
  1. Thyrostatics -Thioamides : inhibitors of peroxidase enzyme - Inhibitors of iodine uptake - Iodine (high dose) : Inhibition of release of thyroid hormones 2. Surgery 3. Radioiodine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

2 Thioamides

A

Thiamazol (methimazol) (A12) Propylthiouracil (PTU) (A12)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Thioamides Mode of action

A

-Blockade of Thyroid-Peroxidase (both functions) -onset - 1-4 weeks (first the previously synthesized hormones will be released)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Thioamides Pharmacokinetics

A

– metabolism: oxidation and glucuronid conjugation – half life of thiamazol: 4-6 h, but duration of action: 24 h – half life of propylthiouracil: 2 h, - 6x daily – all cross the placenta, propylthiouracil has lower amount in breast milk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Thioamides Adverse effect

A
  • maculopapular pruritic rash, fever – agranulocytosis, (leukopenia) – usually first 2-6 weeks – allergy – hypothyreosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Iodine treatment in case of hypertyreosis

A
  • Iodine in high dose (>5mg/d) inhibits the organification, the release of T4 and T3. (mechanism of action is not clear)
  • onset: 24 h. max.: 10-15 d; after that gradual decrease in the effects • Radioiodine therapy • 131I – β emission
  • selective uptake into the thyroid gland • treatment of Graves’ disease, adenomas and iodine storing cancers
  • adverse effect: hypotyreosis (80%) • duration of the treatment: 5-14 d, onset: 10-12 weeks • contraindications: children, pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Hypothyreosis (symptoms and Causes)

A
  1. Causes Immuntyreoditis (Hashimoto), postoperative, drug-induced 2. Subjective symptoms disabilty, weakness, lethargy, devolution, fatigue, feeling cold, poor memory, constipation less frequently: mental depression, weight gain, cardiac problems, hair loss, poor appetite, joint pain 3. Objective symptoms dry skin, hoarseness, slow speech, dry and rough hair, bradycardia, delayed relaxation of tendon reflexes less frequently: swelling of the tongue, cardiomegaly, hypertension, myxedema
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Thyroid hormones used in case of hypothyroidism

A

Levothyroxine (T4) (A12) Liothyronine (T3) (Not in the list) Iodine (A12)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Levothyroxine (T4) (A12)

A
  • Oral, IV - Converted to T3 in target cells, liver, kidneys - Maximum effect is seen after 6-8 weeks of therapy - Hypothyroidism -Side effects: symptoms of thyroid excess
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Liothyronine (T3) (Not in the list)

A
  • Oral, IV - 10X more potent than T4 - Hypothyroidism; used in case of deiodinase enzyme deficiency (T4 cannot be converted to T3) -Side effects: symptoms of thyroid excess
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Iodine (A12)

A
  • Essential mineral nutrient, intake with diet - Daily requirement 150 μg - Iodine salt preparation (KI) for replacement therapy - Oral - Dietary iodine deficiency (endemic goiter) - Thyrotoxicosis crisis (high dose suppresses the gland) -Side effects: cutaneous and mucus membrane irritation, allergic reaction, hypo-/hyper- thyroiditis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Propylthiouracil (PTU) (A12)

A
  • Oral - Duration of action 6-8 h’ - Requires 3-4 weeks for onset of activity (delayed action since the release of preformed thyroid hormones is not affected) - Hyperthyroidism - Used during pregnancy and lactation -Side effects: skin rash, nausea, vasculitis, agranulocytosis, liver dysfunction, hypothyroidism, drug-induced lupus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Thiamazol (methimazol) (A12)

A
  • Oral - Duration of action 24 h’ - Requires 3-4 weeks for onset of activity (delayed action since the release of preformed thyroid hormones is not affected) - No effect on deiodinase enzyme - Hyperthyroidism - Preferred generally (administered once per day) -Side effects: skin rash, nausea, vasculitis, agranulocytosis, liver dysfunction, hypothyroidism, drug-induced lupus, teratogenic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Thyrotoxic crisis (thyroid storm)

A

Rare condition, presents as a life-threatening exacerbation of hyperthyroidism, accompanied by fever, delirium, seizures, coma, vomiting, diarrhea, and jaundice. Mortality rate due to cardiac failure, arrhythmia, or hyperthermia is as high as 30%, even with treatment.

Thyrotoxic crisis is usually precipitated by acute illness (stroke, infection, trauma, diabetic ketoacidosis), surgery (especially on the thyroid), or radioiodine treatment of a patient with partially treated or untreated hyperthyroidism.
Management:
- PTU or methimazole (IV bolus, high dose)
- Potassium-iodide solution (IV)
- β-blockers to control tachycardia and adrenergic symptoms (IV)
- Glucocorticoids to control ophthalmopathy (IV)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Myxedema coma

A

Rare condition, life-threatening exacerbation of hypothyroidism.
Presentation:
- Hypothermia
- Hypoglycemia
- Hypotension
- Altered mental status
Management:
- Thyroid hormones (IV)
- Glucocorticoids (pituitary-adrenal axis is impaired in severe hypothyroidism)
- Supportive management
- Elimination of triggering event (if possible)

17
Q

Hormones releasing from Anterior pituitary

A
  1. Growth hormone (GH)
    Controls growth and glucose metabolism
    Mediated via the somatomedins
  2. ACTH
    Acts on the adrenal gland to stimulate the release of cortisol
  3. Gonadotropins
    Luteinizing hormone ( ovulation, secretion of sex hormones
    Follicle stimulating hormone ( development of follicles
    and sperm cells
  4. Prolactin stimulates breasts to develop milk
  5. TSH
  6. Melanocyte stimulating hormone
    Enhances synthesis of melanin

All the anterior pituitary hormones are under the control of a
hypothalamic hormone , and with the exception of prolactin

18
Q

Hormones releasing from Posterior pituitary

A
  1. Antidiuretic hormone (vasopressin)
    Causes the retention of fluid in the urine
    Combats dehydration
  2. Oxytocin
    •Causes lactation
    •Contractions during child birth
19
Q

2 Growth Hormone (GH) (not in the list)

A
  1. Somatropin (somatotropin)
  • Recombinant form of human GH
    • Subcutaneous injection
    • GH deficiency – dwarfism (genetic, developmental, acquired)
  • Increased final adult height in children with conditions associated with short stature (Prader-Willi syndrome, Turner syndrome)
  • Idiopathic short stature
  • AIDS-associated wasting
  • Malabsorption syndromes in patients who have undergone bowel intestinal resection
    Side effects: pseudotumor cerebri, slipped capital femoral epiphysis, edema, hyperglycemia, scoliosis, risk of asphyxia in severely obese patients with Prader-Willi syndrome and upper airway obstruction or sleep apnea
  1. Asellacrin
  • human GH, is available for parenteral use (IM).
  • Side effects : diabetes, antibodies againts the drug
20
Q

2 GH antagonists (1 in the list)

A

Octreotide (A12) , Lanreotid (not in the list)

Inhibit the release of GH, insulin, glucagon, gastrin

  • Parenteral administration
  • Regular formulation – inject 2-4 times daily
  • Slow-release formulation – inject every 4 w’

Indications

  • Acromegaly (pituitary adenoma), gigantism
  • Endocrine tumors (carcinoid, gastrinoma, glucagonoma, insulinoma, VIPoma)
  • Control of bleeding from esophageal varices
    Side effects: GI disturbances, steatorrhea (due to impaired pancreatic secretion), gall stone, cardiac conduction abnormalities
21
Q

2 Hyperprolactinemia treatment drugs

A

Bromocriptin (A12) , Cabergoline (not in the list)

Dopamine D2 receptor agonist

  • Suppresses pituitary secretion of prolactin and GH (to lesser extent)
  • Oral
  • Indications : hyperprolactinemia , Parkinson disease, stop of lactation
  • Acromegaly (effective only in high doses)
    Side effects : nausea, vomiting, dizziness, neuropsychiatric symptoms
22
Q

Adrenocorticotrop hormone (ACTH, corticotropin)

-Main actions

A
  1. mineralocorticoids, glucocorticoids , androgen
  2. Cortisol changes according to circadian rhythms
  3. Side effects: allergy, salt and water retention
23
Q

corticotrophin (ACTH) analogue

A

Tetracosactrin (Not in the list)

-synthetic, less allergy, long term application, cortisol
effects

-Diagnostic purpose: differentiation of Cushing syndrome and increased
ACTH synthesis
-Parenteral administration

24
Q

Follicle Stimulating Hormone: (FSH)

Mode of Action

A
  1. Interacts with specific receptors (present in the
    plasma membrane of ovaries and testes).
  2. Released during the follicular phase of the menstrual
    cycle and is required for the proper development of
    the ovarian follicles.
  3. In males is responsible for the maturation of the
    germinal elements of the testis and stimulates
    spermatogenesis
25
Q

Luteinizing Hormone : (LH)

Mode of Action

A
  1. In females, LH is required to stimulate oestrogen
    production and for the production of progesterone by
    the corpus luteum of the ovary and is essential for
    ovulation
  2. Very similar to hCG produced in placanta
  3. In males, more precisely called interstitial cell
    stimulating hormone Leydig cells stimulates
    testosterone biosynthesis
26
Q

hMG (Gestyl)

A

Human menopausal gonadotropin (HMG) is isolated from the urine of
postmenopausal women. It is rich in LH and FSH.

  • Uses: Used to treat infertility in women who fail to ovulate despite the

presence of potentially functional ovaries.

  • -Dose: 75 IU is given parenterally for 9 -12 consecutive days to stimulate

ovarian follicular growth and to prime the ovaries to ensure responsiveness
to the subsequent administration of Human Chorionic Gonadotrophin

  • (hCG) which exhibit biological activity similar to that of hCG
27
Q

hCG (Pregnyl)

A

HCG is a hormone produced by human placenta and excreted in the urine of
pregnant women.

Uses:

  1. For the induction of ovulation when injected after priming of ovaries with
    HMG.
  2. To stimulate descent of the testis in male patients with cryptorchidism in
    whom no anatomical obstruction.
  3. Hypogonadism that is secondary to pituitary failure.
28
Q

Oxytocin (A12)

A

Oxytocin receptor agonist
- IV

  • Induction and augmentation of labor
  • Control of uterine hemorrhage after delivery
    Side effects: fetal distress, placental abruption, uterine rupture, fluid retention, hypotension
29
Q

Desmopressin (A12)

A

–V 1 Gq ) VSMC → vasoconstriction
–V 2 Gs ) renal tubule → ↑ water resorbtion

  • Synthetic analogue of ADH (peptide)
  • Prolonged half-life and duration of action compared to endogenous ADH
  • IV, intranasal, oral, subcutaneous
  • Central diabetic insipidus
  • Hemophilia A – factor VIII deficiency
  • Von-Willebrand disease
    Side effects: GI disturbances, headache, hyponatremia, allergic reaction
30
Q

Drugs affecting ADH hormone antagonists

A
  1. Lithium (A31)
  2. Tolvaptan (B23)
    competitive vasopressin receptor 2
    (V2) antagonist

Indications:
Hyponatremia
Syndrome of in appropiate ADH
secretion

31
Q
A